Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :1637
Small font sizeDefault font sizeIncrease font size
Read this article

 


    Article Cited by others

ORIGINAL ARTICLE

A retrospective clinical study of bevacizumab combined with gemcibabine or paclitaxel in the treatment of recurrent ovarian cancer

Wu M D, Wang Y, Ding T, Zhou Y F, Song J, Liu X H, Wei M H, Yang Q H, Zhou J, Wang S H, Lv Q Y

Year : 2014| Volume: 51| Issue : 7 | Page no: 103-105

   This article has been cited by
 
1 Platinum-resistant recurrent ovarian cancer with long survival on bevacizumab and gemcitabine
Shinichi Komiyama,Tsuyoki Kugimiya,Chiaki Takeya,Rena Takahashi,Kaneyuki Kubushiro
Journal of Obstetrics and Gynaecology Research. 2018; 44(7): 1330
[Pubmed]  [Google Scholar] [DOI]
2 Addition of bevacizumab to gemcitabine for platinum-resistant recurrent ovarian cancer: a retrospective analysis
Kazuki Takasaki,Morikazu Miyamoto,Masashi Takano,Hiroaki Soyama,Tadashi Aoyama,Hiroko Matsuura,Kento Kato,Takahiro Sakamoto,Mika Kuwahara,Hideki Iwahashi,Hiroki Ishibashi,Tomoyuki Yoshikawa,Kenichi Furuya
Cancer Chemotherapy and Pharmacology. 2018; 81(5): 809
[Pubmed]  [Google Scholar] [DOI]

 

  Site Map | What's new | Copyright and Disclaimer
  Online since 1st April '07
  2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow